Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other
companies in this sector in China:
Livzon Pharmaceutical Group Incorporated
sales of 7.65 billion Chinese Renmimbi [US$1.16 billion]
of which 42%
was Western Medicine),
Huapont-Nutrichem Co Ltd
(7.09 billion Chinese Renmimbi [US$1.08 billion]
of which 68%
was Agricultural Business), and
North China Pharmaceutical, Limited
(8.08 billion Chinese Renmimbi [US$1.23 billion]
of which 43%
was Chemical Preparation Medicine).
During the year ended December of 2016, sales at
Chongqing Taiji Industry (Group) were 7.78 billion Chinese Renmimbi (US$1.18 billion).
increase of 8.7%
versus 2015, when the company's sales were 7.16 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group)
(and since 2011, sales have increased a total of 22%).
Sales of Industrial saw an increase
that was more than double the company's growth rate: sales were up
18.8% in 2016, from
3.04 billion Chinese Renmimbi to 3.61 billion Chinese Renmimbi.
Not all segments of Chongqing Taiji Industry (Group) experienced an increase in sales in 2016:
sales of Other fell 19.2% to 109.19 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Chongqing Taiji Industry (Group) also experienced decreases in sales in
Service (down 9.3% to 11.54 million Chinese Renmimbi)